Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
DNA and Cell Biology|May 25, 2021
<i>TEAD4</i> is an Immune Regulating-Related Prognostic Biomarker for Bladder Cancer and Possesses Generalization Value in Pan-CancerJirong Wang, Chengquan Shen, Jipeng Zhang, et al.
Investigative and Clinical Urology|May 7, 2024
Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancerRuize Qin, Xiaocheng Ma, Shi Pu, et al.
Discover Oncology|May 21, 2026
Integrating machine learning and structural analysis to decipher benzo[a]pyrene-induced bladder cancer networksXinzhao Zhao, Ruize Qin, Chengquan Shen, et al.
Artificial Cells, Nanomedicine, and Biotechnology|January 18, 2021
Construction of a immune-associated genes based prognostic signature in bladder cancerChengquan Shen, Liping Wang, XueCheng Yang, et al.
Cancer Letters|June 1, 2024
N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitinationChengquan Shen, Jing Liu, Fei Xie, et al.
Disease Markers|January 18, 2021
Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder CancerChengquan Shen, Ting Xu, Yefeng Sun, et al.
European Journal of Medical Research|December 20, 2022
High expression of GMNN predicts malignant progression and poor prognosis in ACCXinzhao Zhao, Xuezhou Zhang, Shixiu Shao, et al.
Journal for Immunotherapy of Cancer|February 3, 2026
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancerChengquan Shen, Changxue Liu, Ding Hu, et al.
Journal of Translational Medicine|February 28, 2025
The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world studyHuaixi Ge, Changxue Liu, Chengquan Shen, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2026
NOTCH3 regulates myofibroblastic CAF differentiation via the P62-ROS signaling axis to promote bladder cancer progressionDing Hu, Chengquan Shen, Changxue Liu, et al.
Pageof 2